Cargando…
Poster 2010: A study assessing the safety and efficacy of subcutaneous immunotherapy with a dust mite vaccine with the adjuvant l-tyrosine in a highly sensitized population in a Latin-American city
Autores principales: | Villa, Ricardo Cardona, Fernando Chinchilla Mejia, Carlos, Helena Ramirez Giraldo, Ruth, Margarita Olivares Gomez, Maria, Calvo, Victor, Maspero, Jorge F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082146/ http://dx.doi.org/10.1186/1939-4551-7-S1-P22 |
Ejemplares similares
-
Systemic Reactions to Dust Mite Subcutaneous Immunotherapy: A 3-Year Follow-up Study
por: Dong, Xiang, et al.
Publicado: (2016) -
Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases
por: Yang, Yaqi, et al.
Publicado: (2021) -
House Dust Mite Subcutaneous Immunotherapy and Lung Function Trajectory in Children and Adolescents with Asthma
por: Nogami, Kazutaka, et al.
Publicado: (2022) -
Sensitization by subcutaneous route is superior to intraperitoneal route in induction of asthma by house dust mite in a murine mode
por: Aun, Marcelo Vivolo, et al.
Publicado: (2015) -
A Retrospective Study of Clinical Response Predictors in Subcutaneous Allergen Immunotherapy With House Dust Mites for Allergic Rhinitis
por: Lee, Ji-Ho, et al.
Publicado: (2018)